Vasculitis: A Collection of Pearls and Myths

Kussmaul, 1866, Über eine bisher nicht beschriebene eigenthumliche arterienerkrankung (periarteritis nodosa), die mit morbus brightii und rapid fortschreitender allgemeiner muskellahmung einhergeht, Dtsch Arch Klin Med, 1, 484 Matteson, 1996 Kussmaul, 1866, Aneurysma verminosum hominis: verlaufige nachricht, Deutsches Archiv fur klinische Medizin, 1, 125 Stone, 2001, Vasculitis: a collection of pearls and myths, Rheum Dis Clin NA, 27, 677, 10.1016/S0889-857X(05)70231-3 2005, Etanercept plus standard therapy in patients with Wegener's granulomatosis, N Engl J Med, 352, 351, 10.1056/NEJMoa041884 Reinhold-Keller, 2000, An interdisciplinary approach to the care of patients with Wegener's granulomatosis. Long term outcome in 155 patients, Arthritis Rheum, 43, 1021, 10.1002/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J Hoffman, 1992, Wegener's granulomatosis: an analysis of 158 patients, Ann Intern Med, 116, 488, 10.7326/0003-4819-116-6-488 Goek, 2005, Randomized controlled trials in ANCA-associated vasculitis, Curr Opin Rheumatol, 17, 257, 10.1097/01.bor.0000160777.28259.c2 Thomas, 2004, Pneumocystis pneumonia, N Engl J Med, 350, 2487, 10.1056/NEJMra032588 Fauci, 1974, Cyclophosphamide and lymphocyte subpopulations in Wegener's granulomatosis, Arthritis Rheum, 17, 355, 10.1002/art.1780170404 Haubitz, 2002, Cyclophosphamide phramacokinetics and dose requirements in patients with renal insufficiency, Kidney Int, 61, 1495, 10.1046/j.1523-1755.2002.00279.x Jayne, 2003, Randomised trial of cyclophosphamide versus azathioprine during remission in ANCA-associated systemic vasculitis, N Engl J Med, 349, 36, 10.1056/NEJMoa020286 2002, Design of the Wegener's granulomatosis etanercept trial (WGET), Control Clin Trials, 23, 450, 10.1016/S0197-2456(02)00209-X Langford, 1999, A staged approach to the treatment of Wegener's granulomatosis: induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance, Arthritis Rheum, 42, 2666, 10.1002/1529-0131(199912)42:12<2666::AID-ANR24>3.0.CO;2-E Teml, 2007, Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing, Clin Pharmacokinet, 46, 187, 10.2165/00003088-200746030-00001 Sinico, 2003, Azathioprine hypersensitivity: report of two cases and review of the literature, J Nephrol, 16, 272 Sneller, 1995, An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone, Arthritis Rheum, 38, 608, 10.1002/art.1780380505 Stegeman, 1996, Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapse in Wegener's granulomatosis, N Engl J Med, 335, 16, 10.1056/NEJM199607043350103 Guillevin, 1998, Treatment of polyarteritis nodosa and microscopic polyangiitis, Arthritis Rheum, 41, 2100, 10.1002/1529-0131(199812)41:12<2100::AID-ART3>3.0.CO;2-J Pagnoux, 2006, Polyarteritis nodosa: clinical description and long-term follow-up of the 351 patients from the French Vasculitis Study Group, Arthritis Rheum, 49, S420 Collins, 2000, Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy, Neurology, 55, 636, 10.1212/WNL.55.5.636 Mathew, 2007, Treatment of vasculitic peripheral neuropathy: a retrospective analysis of outcome, QJM, 100, 41, 10.1093/qjmed/hcl125 Vallat, 2007, Case 9-2007: a 27 year-old woman with pain and swelling of the legs, N Engl J Med, 356, 1252, 10.1056/NEJMcpc079003 Talor, 2007, Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA) by immunofluorescence antibodies to minor target antigens in patients with anti-neutrophil cytoplasmic antibodies, Clin Exp Immunol, 150, 42, 10.1111/j.1365-2249.2007.03453.x Stone, 2001, “Essential” cutaneous vasculitis: what every rheumatologist should know about vasculitis of the skin, Curr Opin Rheumatol, 13, 23, 10.1097/00002281-200101000-00005 Frances, 2005, Dermatologic manifestations of the antiphospholipid syndrome, Arthritis Rheum, 52, 1785, 10.1002/art.21041 Uthman, 2006, Livedo racemosa: a striking dermatological sign for the antiphospholipid syndrome, J Rheumatol, 33, 2379 Stockhammer, 1993, Sneddon's syndrome: diagnosis by skin biopsy and MRI in 17 patients, Stroke, 24, 685, 10.1161/01.STR.24.5.685 Yazici, 1984, A comparative study of the pathergy reaction among Turkish and British patients with Behcet's disease, Ann Rheum Dis, 43, 74, 10.1136/ard.43.1.74 Ehrmann, 1907, Ein gefaessprozess bei lues, Wien Med Wochenschr, 57, 777 Frances, 1999, Sneddon's syndrome with and without aPL, Medicine, 78, 209, 10.1097/00005792-199907000-00001 Smetana, 2002, Does this patient have temporal arteritis?, JAMA, 287, 92, 10.1001/jama.287.1.92 Small, 1991, Wegener's granulomatosis presenting as temporal arteritis, Arthritis Rheum, 34, 220, 10.1002/art.1780340215 Lee, 2006, Antiplatelet and anticoagulant therapy in patients with giant cell arteritis, Arthritis Rheum, 54, 3306, 10.1002/art.22141 Nesher, 2004, Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis, Arthritis Rheum, 50, 1332, 10.1002/art.20171 Stone, 2007, Antiplatelet versus anticoagulant therapy in patients with giant cell arteritis: which is best?, Nat Clin Pract Rheumatol, 3, 136, 10.1038/ncprheum0431 Hayreh, 2002, Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature, Acta Ophthalmol Scand, 80, 355, 10.1034/j.1600-0420.2002.800403.x Miller, 2001, Visual manifestations of temporal arteritis, Rheum Dis Clin North Am, 27, 781, 10.1016/S0889-857X(05)70235-0 Razavi, 2004, Steroid-responsive Charles Bonnet syndrome in temporal arteritis, J Neuropsychiatry Clin Neurosci, 16, 505, 10.1176/jnp.16.4.505 Wilkinson, 1972, Arteries of the head and neck in giant cell arteritis: a pathological study to show the pattern of arterial involvement, Arch Neurol, 27, 378, 10.1001/archneur.1972.00490170010003 Caselli, 1988, Neurologic disease in biopsy-proven giant cell (temporal) arteritis, Neurology, 38, 352, 10.1212/WNL.38.3.352 Salvarani, 2006, Giant cell arteritis: involvement of intracranial arteries, Arthritis Rheum, 55, 985, 10.1002/art.22359 Esteban, 2001, Small-vessel vasculitis surrounding a spared temporal artery: clinical and pathological findings in a series of twenty-eight patients, Arthritis Rheum, 44, 1387, 10.1002/1529-0131(200106)44:6<1387::AID-ART232>3.0.CO;2-B Karahaliou, 2006, Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis, Arthritis Res Ther, 8, R116, 10.1186/ar2003 Salvarani, 2002, Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis?, Ann Intern Med, 137, 232, 10.7326/0003-4819-137-4-200208200-00006 Hellmann, 2003, Domains of quality of life important to patients with giant cell arteritis, Arthritis Rheum, 49, 819, 10.1002/art.11464 Hunder, 1975, Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study, Ann Intern Med, 82, 613, 10.7326/0003-4819-82-5-613 Hoffman, 2002, A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis, Arthritis Rheum, 46, 1309, 10.1002/art.10262 Hall, 1983, The therapeutic impact of temporal artery biopsy, Lancet, 2, 1217, 10.1016/S0140-6736(83)91269-2 Horton, 1937, Arteritis of temporal vessels: report of 7 cases, Proc Staff Meet Mayo Clin, 12, 548 Horton, 1932, Undescribed forms of arteritis of temporal vessels, Proc Staff Meet Mayo Clin, 7, 700 Gilmour, 1941, Giant-cell chronic arteritis, J Pathol, 53, 263, 10.1002/path.1700530210 Brack, 1999, Disease pattern in cranial and large-vessel giant cell arteritis, Arthritis Rheum, 42, 311, 10.1002/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F Tso, 2002, Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment, Arthritis Rheum, 46, 1634, 10.1002/art.10251 Seo, 2002, Large-vessel vasculitis, Arthritis Care Res, 51, 128, 10.1002/art.20083 Boyev, 1999, Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis, Am J Ophthalmol, 128, 211, 10.1016/S0002-9394(99)00101-4 Pless, 2000, Concordance of bilateral temporal artery biopsy in giant cell arteritis, J Neuroophthalmol, 20, 216, 10.1097/00041327-200020030-00012 Regan, 2000, Ethnic disparity in the incidence of temporal arteritis: a 32-year experience at an urban medical center, Arthritis Rheum, 43, S128 Olopade, 1997, Giant cell arteritis manifesting as chronic cough and fever of unknown origin, Mayo Clin Proc, 72, 1048, 10.4065/72.11.1048 Salvarani, 2001, Giant cell arteritis with a low erythrocyte sedimentation rate: frequency of occurence in a population-based study, Arthritis Rheum, 45, 140, 10.1002/1529-0131(200104)45:2<140::AID-ANR166>3.0.CO;2-2 Lessell, 1999, Nonarteritic anterior ischemic optic neuropathy: enigma variations, Arch Ophthalmol, 117, 386, 10.1001/archopht.117.3.386 Birchmore, 1996, IgA multiple myeloma presenting as HSP/polyarteritis nodosa overlap, Arthritis Rheum, 39, 698, 10.1002/art.1780390425 Jayne, 2007, Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis, J Am Soc Nephrol, 18, 2180, 10.1681/ASN.2007010090 Wegener, 1936, Uber generalisierte, septische gefasserkrankungen, Verh Dtsch Ges Pathol, 29, 202 Papaionnides, 2002, Asymptomatic splenic infarction in Wegener's granulomatosis, Ann Rheum Dis, 61, 185, 10.1136/ard.61.2.185-a Leavitt, 1990, The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis, Arthritis Rheum, 33, 1101, 10.1002/art.1780330807 Mahr AD, Neogi T, LaValley MP, et al. Assessment of the item selection and weighting in the Birmingham vasculitis activity score for Wegener's granulomatosis (BVAS/WG) [Submitted]. Al-Hakeem, 2007, Extranodal NK/T-cell lymphoma, nasal type, Oral Oncol, 43, 4, 10.1016/j.oraloncology.2006.03.011 Wiesner, 2004, Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis, Arthritis Rheum, 50, 2954, 10.1002/art.20479 Sadiq, 2003, Posterior scleritis: an unusual presentation of facial pain, Br J Oral Maxillofac Surg, 41, 62, 10.1016/S0266-4356(02)00254-1 Genereau, 1999, Temporal artery biopsy. A diagnostic tool for systemic necrotizing vasculitis, Arthritis Rheum, 42, 2674, 10.1002/1529-0131(199912)42:12<2674::AID-ANR25>3.0.CO;2-A Jayne, 1995, ANCA and predicting relapse in systemic vasculitis, QJM, 88, 127 Finkielman, 2007, Antineutrophil cytoplasmic antibodies against proteinase 3 do not predict disease relapses in Wegener's granulomatosis, Ann Intern Med, 147, 611, 10.7326/0003-4819-147-9-200711060-00005 Boomsma, 2000, Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels. A prospective study, Arthritis Rheum, 43, 2025, 10.1002/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O Merkel, 2005, Incidence of venous thrombotic events among patients with Wegener's granulomatosis, Ann Intern Med, 142, 620, 10.7326/0003-4819-142-8-200505030-00011 Wegener, 1939, Über eine eigenartige rhinogene granulomatose mit besonderer Beteiligung des arteriensystems und der Nieren, Beitr Pathol, 102, 36 Sebastian, 2007, Anti-endothelial cell antibodies in patients with Wegener's granulomatosis: prevalence and correlation with disease activity and manifestations, J Rheumatol, 34, 1027 Sebastian, 2007, The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without a history of a thrombotic event, J Rheumatol Godman, 1954, Wegener's granulomatosis: pathology and review of the literature, Arch Pathol Lab Med, 58, 533 Churg, 2001, Recent advances in the diagnosis of Churg-Strauss syndrome, Mod Pathol, 14, 1284, 10.1038/modpathol.3880475 Boin, 2006, Churg-Strauss syndrome presenting with salivary gland enlargement and respiratory distress, Arthritis Rheum, 55, 167, 10.1002/art.21708 Guillevin, 1999, Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients, Medicine (Baltimore), 78, 26, 10.1097/00005792-199901000-00003 Keogh, 2003, Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists, Am J Med, 115, 284, 10.1016/S0002-9343(03)00359-0 Sablé-Fourtassou, 2005, Antineutrophil cytoplasmic antibodies and the churg-strauss syndrome, Ann Intern Med, 143, 632, 10.7326/0003-4819-143-9-200511010-00006 Wechsler, 2000, Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma, Chest, 117, 708, 10.1378/chest.117.3.708 Pagnoux, 2007, Churg-Strauss syndrome, Curr Opin Rheumatol, 19, 25, 10.1097/BOR.0b013e3280119854 Eschun, 2003, Pulmonary interstitial fibrosis as a presenting manifestation in perinuclear antineutrophilic cytoplasmic antibody microscopic polyangiitis, Chest, 123, 297, 10.1378/chest.123.1.297 Homma, 2004, Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides, Respirology, 9, 190, 10.1111/j.1440-1843.2004.00581.x Birnbaum, 2007, Microscopic polyangiitis presenting as a ‘pulmonary-muscle’ syndrome: does alveolar hemorrhage contribute to the mechanism of pulmonary fibrosis?, Arthritis Rheum, 56, 20, 10.1002/art.22633 Guillevin, 1999, Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients, Arthritis Rheum, 42, 421, 10.1002/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6 Duggan, 2007, Case records of the Massachusetts General Hospital. Case 23–2007. A 9-year-old boy with bone pain, rash, and gingival hypertrophy, N Engl J Med, 357, 392, 10.1056/NEJMcpc079017 Bosch, 2006, Antineutrophil cytoplasmic antibodies, Lancet, 368, 404, 10.1016/S0140-6736(06)69114-9 Prasad, 2006, Sum of the parts, N Engl J Med, 355, 2468, 10.1056/NEJMcps060364 Musset, 1992, Characterization of cryoglobulins by immunoblotting, Clin Chem, 38, 798, 10.1093/clinchem/38.6.798 Cacoub, 1999, Extrahepatic manifestations of chronic hepatitis C, Arthritis Rheum, 42, 2204, 10.1002/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D Vassilopoulos, 2002, Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies, Arthritis Rheum, 46, 585, 10.1002/art.10107 Vollertsen, 1986, Cogan's syndrome: 18 cases and a review of the literature, Mayo Clin Proc, 61, 344, 10.1016/S0025-6196(12)61951-X Gluth, 2006, Cogan syndrome: a retrospective review of 60 patients throughout a half century, Mayo Clin Proc, 81, 483, 10.4065/81.4.483 Grasland, 2004, Typical and atypical Cogan's syndrome: 32 cases and review of the literature, Rheumatology, 43, 1007, 10.1093/rheumatology/keh228 Calabrese, 2007, Narrative review: reversible cerebral vasoconstriction syndromes, Ann Intern Med, 146, 34, 10.7326/0003-4819-146-1-200701020-00007 Kural-Seyahi, 2003, The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center, Medicine (Baltimore), 82, 60, 10.1097/00005792-200301000-00006 Yazici, 1981, A controlled survery of sacroiliitis in Behcet's disease, Ann Rheum Dis, 40, 558, 10.1136/ard.40.6.558 Koc, 1992, Vascular involvement in Behcet's disease, J Rheumatol, 19, 402 Lie, 1992, Vascular involvement in Behcet's disease: arterial and venous and vessels of all sizes, J Rheumatol, 19, 341 Kahraman, 2003, Long-term course of deep venous thrombosis in patients with Behcet's disease, Arthritis Rheum, 48, S385 Puechal, 2007, Thromboangiitis obliterans or Buerger's disease: challenges for the rheumatologist, Rheumatology, 46, 192, 10.1093/rheumatology/kel388 Horton, 1938, The outlook in thromboangiitis obliterans, JAMA, 111, 2184, 10.1001/jama.1938.02790500022006 Lie, 1987, Thromboangiitis obliterans (Buerger's disease) in women, Medicine (Baltimore), 66, 65, 10.1097/00005792-198701000-00002 Olin, 2000, Thromboangiitis obliterans (Buerger's disease), N Engl J Med, 343, 864, 10.1056/NEJM200009213431207 Sterne, 1960, Arteritis caused by cannabis indica, Arch Mal Coeur, 53, 143 Combemale, 2005, Cannabis arteritis, Br J Dermatol, 152, 166, 10.1111/j.1365-2133.2005.06340.x Disdier, 1999, Arterite du cannabis versus maladie de leo buerger. Discussion nosologique a propos de deux nouveaux cas, Presse Med, 28, 71 Hill, 1974, A rational basis for management of patients with the Buerger syndrome, Br J Surg, 61, 476, 10.1002/bjs.1800610615 Puechal, 1999, Rheumatic manifestations in patients with thromboangiitis obliterans (Buerger's disease), J Rheumatol, 26, 1764 Hirai, 1979, Arterial obstruction of the upper limb in Buerger's disease: its incidence and primary lesion, Br J Surg, 66, 124, 10.1002/bjs.1800660213 Sasaki, 2000, Current status of thromboangiitis obliterans (Buerger's disease) in Japan, Int J Cardiol, 75, S175, 10.1016/S0167-5273(00)00190-X Quenneville, 1981, Subungual splinter hemorrhage: an early sigh of thromboangiitis obliterans, Angiology, 32, 424, 10.1177/000331978103200609 Puechal, 1995, Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients, Arthritis Rheum, 38, 1618, 10.1002/art.1780381114